Gene silencing via RNA interference (RNAi) is rapidly evolving as a personalized approach
to cancer treatment. The effector molecules—small interfering RNAs (siRNAs) and …

With a lifetime risk estimated to be one in eight in industrialized countries, breast cancer is
the most frequent type of cancer among women worldwide. Patients are often treated with …

Mammogram inspection in search of breast tumors is a tough assignment that radiologists
must carry out frequently. Therefore, image analysis methods are needed for the detection …

Breast cancer is a heterogeneous disease manifesting diversity at the molecular,
histological and clinical level. The development of breast cancer classification was centered …

Breast cancer (BC) is a heterogeneous malignancy that still represents the second cause of
cancer-related death among women worldwide. Due to the heterogeneity of BC, the correct …

Triple-negative breast cancer (TNBC) is sometimes mistaken for fibroadenoma due to its
tendency to show benign morphology on breast ultrasound (US) albeit its aggressive nature …

This meta-analysis aimed to estimate and compare sensitivity, specificity, positive-(PPV) and
negative predictive value (NPV) of magnetic resonance imaging (MRI) for predicting …

Breast cancer remains a highly prevalent disease with considerable inter-and intra-tumoral
heterogeneity complicating prognostication and treatment decisions. The utilization and …

Preclinical, clinical, and epidemiological studies indicate that vitamin D3 (VD) deficiency is a
risk factor for the development of breast cancer. Underlying mechanisms include the ability …

Breast cancer is the leading cause of cancer-related deaths in women worldwide.
GLOBOCAN estimated about 1.7 million new cases of breast cancer diagnoses worldwide …